The search for antiaging drugs is a key component of gerontology research. A few drugs with positive effects on life span in model organisms have been found. Here, we report that 2,5-dimethyl-celecoxib, a derivative of the anti-inflammatory drug celecoxib, can extend Drosophila life span and delay aging by a mechanism involving insulin signaling and target of rapamycin signaling. Importantly, its positive effects were apparent when the treatment window was restricted to the beginning of life or the later half. 2,5-Dimethyl-celecoxib-induced longevity was also associated with improvements in physical activity, intestinal integrity, and increased autophagy. In addition, 2,5-dimethyl-celecoxib exhibited protective effects against several kinds of stress such as starvation and heat. The generally positive effects of 2,5-dimethyl-celecoxib on both health and life span, combined with its mode of action via evolutionarily conserved signaling pathways, indicate that it has the potential to become an effective antiaging drug.
The demographic shift towards population aging in almost all countries underpins the current search for antiaging therapies. Among various interventions, drugs that affect life span offer great promise as no genetic modifications are involved, and they can be used in a time-and dose-dependent manner. Furthermore, compared to mild dietary restriction (DR), which also extends life in numerous organisms, pharmacological antiaging regimens are easier to implement as they circumvent the need for strict self-discipline.
A few drugs have been demonstrated to have positive effects on life span, such as rapamycin (1, 2) and metformin (3) . The effects of these drugs on signaling are known to be involved in insulin and insulin-like growth factor-like signaling (IIS) and/or the mechanistic target of rapamycin (TOR) pathways and the downregulation of these pathways can enhance life span (4) . Some of these drugs have been demonstrated to be effective even when administered for only a short portion of total life span (5, 6) . However, one of the major risks with drugs is their potential for side-effects that introduce health costs. For example, rapamycin has potent immunosuppressive properties and its long-term administration may increase the risk of proteinuria and pneumonitis (4) , while high doses of metformin in mammals is associated with gastrointestinal bloating and diarrhea (3) . Thus, there is always an interest in discovering drugs with antiaging properties, especially repurposing drugs that already have FDA approval.
Celecoxib is an FDA-approved nonsteroidal anti-inflammatory drug that is used to treat pain and inflammation in the clinic (7) and it was prescribed to 2.4 million people around the world in 2011. Celecoxib, like all coxibs, is a selective inhibitor of cyclooxygenase-2 (COX-2), but it also interacts with dozens of other molecular targets, including carbonic anhydrases and a variety of ion channels (8, 9) .
It is also thought to operate on and reduce signaling through the insulin signaling pathway indicating that it may have antiaging properties (10) . Indeed, administration to worms shows that it can extend life span by inhibiting 3′-phosphoinositide-dependent kinase-1(PDK-1) (11) . However, the long-term use of celecoxib may cause life-threatening complications due to its COX-2 inhibitory function that can cause cardiovascular disease, renal injury, and gastrointestinal toxicity (7). 2,5-Dimethyl-celecoxib (DMC) is a derivative of celecoxib that lacks COX inhibitory function and, in mice, faithfully mimics a number of its positive effects on antitumor (12) (13) (14) . Moreover, it shows inhibition of both IIS and TOR signaling in a mouse model of inherited dilated cardiomyopathy (7) . Therefore, DMC may be an alternative to celecoxib as a drug to slow aging which lack COX-2 inhibitory effect.
The effects of DMC on life span have not yet been tested, so we assayed its action using the fruit fly Drosophila melanogaster. Although Drosophila lack COX-like enzymes, it still is a good model animal to study the potential antiaging effect of DMC, because various aging-related pathways such as IIS and TOR are evolutionarily conserved. We found that at optimal doses, DMC can extend life span both in males and females and even acted to promote longer life when flies were exposed to the drug for only a part of their lives. Its ability to modulate life span required both IIS and TOR signaling to be intact. Together, our results show that DMC could increase both life span and health span in flies. These data could indicate an evolutionarily conserved antiaging role for DMC.
Materials and Methods

Fly Stocks and Husbandry
The wild-type stock Dahomey was collected in 1970 in Dahomey (now Benin). da-GS-gal4 (15), PDK1-RNAi (CG1210 BL36071), Atg5-RNAi (CG1643 BL34899), Atg1-RNAi (CG10967 BL35177), 4E-BP-RNAi (CG8846 BL36667), and S6K-RNAi (CG10539 BL33636) were obtained from the Bloomington Drosophila Stock Center (http://flystocks.bio.indiana.edu). Akt-RNAi (CG4006 V2902) was obtained from the Vienna Drosophila RNAi Center. RNAi lines were backcrossed into w1118 for at least six generations. The males of all RNAi flies were crossed with da-GS-GAL4 virgin females, F1 generation females were collected and, after mating, transferred to food containing 20 µM RU486 for activation. All stocks were maintained at 25°C on a 12 hour:12 hour light:dark cycle at constant humidity using 1SY food (16) , but experiments were conducted on holidic medium (with amino acids in the ratio of Yaa (17)) at 25°C on a 12 hour:12 hour light:dark cycle at constant humidity. Drugs (RU486 [20 µM] , DMC, and rapamycin) were added into the food after cooling it to 50°C. For all experiments, flies were reared at standard larval density and eclosed adults were collected over a 12-hour period. Flies were mated for 48 hours before sorting into single sexes.
Life-Span Analysis
Flies that eclosed over a 36-hour period were collected and allowed to mate for approximately 60 hours. Females were randomly allocated to the experimental food treatments and housed in plastic vials containing food at a density of 10 flies per vial, with 10 vials per condition (n = 100). Flies were transferred to a fresh food source every 2 days, during which any deaths and censors were recorded. DMC (Sigma) was dissolved in ethanol and added to holidic medium. For control food, ethanol alone was added. All life-span experiments have been repeated at least twice.
Fecundity
Eggs were collected over 24-hour periods every 2 days during lifespan experiments. The number of eggs laid per vial at each time point was counted. For each condition and each time point, 10 vials were counted. Each vial contained 10 flies. Data are reported as cumulative eggs laid per female fly for the 10 counts.
Smurf Assay
Unless stated otherwise, flies were aged on standard holidic medium until the day of Smurf assay. Dyed medium was prepared using standard media with dyes added at a concentration of 2.5% (wt/vol). Blue dye No. 1 was purchased from Sigma-Aldrich. Flies were maintained on dyed medium for 9 hours. A fly was counted as a Smurf when dye coloration could be observed outside of the digestive tract (18) .
Selective Plates for Bacterial Cultures
Selective plates were generated according to the following recipes (19) : 
Food Intake Assay
Flies were reared as for the survival analysis and placed at five per vial with no anesthesia 24 hours prior to observation. Ten-dayold flies were put on standard holidic food containing 2.5% blue dye (wt/vol; Blue No. 1) and 0.5 µM DMC or ethanol as a control. Feeding for 1 hour, flies were then frozen and homogenized in 200 mL of distilled water. A further 800 mL of distilled water was added and the suspension passed through a 0.22-mm Millex filter (Millipore Corporation, Bedford, MA) to remove debris and lipids. The absorbance of the liquid sample was then measured at 629 nm (Thermo Scientific NanoDrop 2000c). Age-matched flies exposed to nondyed food were used as the baseline during spectrophotometry. The amount of labeled food in the fly was calculated from a standard curve made by serial dilution in water of a sample of blue food (20) .
Measurement of Vertical Climbing Ability
Vertical locomotion (climbing) was assessed by the rapid iterative negative geotaxis assay. For each treatment group, 150 flies were placed in 10 vials. The vial was gently shaken until all flies were displaced to the bottom of the vial. Flies were then permitted to climb for 4 seconds and then photographed. Two groups (DMC-fed and controls) were assayed simultaneously. The assay was repeated five times with independent groups of flies. The distance climbed was measured in Adobe Photoshop and the speed was calculated by distance/s (21).
Stress Assays
Hundred flies per sex per treatment were fed for 10 days with DMC or control diet. For the H 2 O 2 and paraquat assays, flies were fed 20 mM paraquat or 5% H 2 O 2 diluted in a 5% glucose solution supplied on filter paper. For the desiccation assay, flies were housed in empty vials and deaths were recorded every 3 hours (21) . For the starvation assay, flies were housed in vials containing 1.5% agarose to provide moisture, but no nutritional value. Deaths were recorded every day. For the heat assay, flies were housed in empty vials at 37°C, and deaths were recorded every hour.
Measurement of Body Weight
Flies were fed for 10 days with DMC or a control diet. These flies were then collected with CO 2 and weighed (10 flies per vial).
Western Blots
Total protein of fruit flies was extracted with Tissue or Cell Total Protein Extraction Kit (Sangon Biotech C510003). Approximately 40 µg of protein extract was loaded per lane on polyacrylamide gel. Proteins were separated and transferred to polyvinylidene fluoride membrane. Primary antibodies used were as follows: α-Tubulin Antibody (Sigma T9026), Phospho-4E-BP Antibody (Cell Signaling 2855), Akt Antibody (Cell Signaling Technologies #9272), Phospho-AKT pThr308 Antibody (Invitrogen 44-602G). All western blots experiments were repeated at least twice.
LysoTracker Staining, Imaging, and Image Analysis For LysoTracker staining, complete guts were removed from flies that had been maintained on 0.5 µM DMC or control food for 20 days (n = 5 flies in each group). Dissections were performed in phosphatebuffered saline. Each gut was mounted into a custom made imaging chamber and stained with LysoTracker DS Red DND-99 (Invitrogen, Molecular Probes,) 1 µM for 3 minutes. Each preparation was then washed three times with phosphate-buffered saline and mounted in mounting medium (Mounting medium, Vectashield, H1200) (1). Imaging was performed using a fluorescence microscope with ×10 objective and ×10 eyepiece. Numbers of LysoTracker-stained puncta were analyzed by Image J.
Triacylglyceride Assay
Flies were fed for 10 days with DMC or a control diet, and each group was divided into six repeats, every repeat containing 10 flies. Flies were then frozen in liquid nitrogen for triacylglyceride content quantification by using Triglyceride assay kit (Nanjing Jiancheng Bioengineering Institute).
Analysis of Gene Expression
Flies were fed for 20 days with DMC or a control diet then frozen in liquid nitrogen for RNA quantification. Total RNA from 10 flies was extracted using Trizol and cDNA was synthesized using Superscript II (Invitrogen). Real-time PCR was performed in triplicates using SYBR Green, on Biorad IQ5 instrument and the following primer pairs were used.
Fold changes in expression were calculated using the 2 −ΔΔCt method and normalized to actin (housekeeping gene) levels. Results are average+/-standard deviation of at least 3 independent biological samples run in triplicates.
Results
DMC Extends Drosophila Life Span
In previous work, we developed a holidic medium for flies (17) , which has several advantages over yeast-based media. In particular, it provides a more consistent source of nutrition over time and yields more stable life-span outcomes and secondly, components of the diet become more bioavailable, which has the advantage that the effects of drugs manifest at much lower concentrations. We used this medium to examine whether DMC could extend life span in the fly ( Figure 1A ). We tested a range of doses (0.05, 0.2, 0.5, 2, and 10 µM) and found positive effects on life span at the intermediate doses 0.2 µM (increased mean life span up to 4.8%, from 66.9 to 70.1 days, p = .03) and 0.5 µM (increased mean life span up to 10.2%, from 66.9 to 73.7 days, p < .0001) but no effect below and above these concentrations (Figure 1B and C; Supplementary Table  S1 ) reflecting a typical nonmonotonic dose-response curve. The lifespan effect of DMC was not gender specific, with 0.5 µM DMC also extending male life span up to 9.1%, from 41.9 to 45.7 days (p = .01) ( Figure 1D ; Supplementary Figure S1 and Table S1 ). In the following experiments, we chose 0.5 µM as the best dose for the subsequent experiments because of its positive effect on life span of both sexes. To assess if the life-span benefits of DMC were indirectly caused by the drug being aversive and/or repellant and so caused the flies to self-impose DR, we assessed the effect of drug on food ingestion. During a 1-hour feeding assay, DMC had no effect on food consumption (p > .05; Supplementary Figure S2A ), nor did it have any effect on body mass of either sex after 10 days of exposure (p > .05; Supplementary Figure S2B ), which is a known correlate of DR. Finally, we assessed the effect of DMC on life span for a range of concentrations of dietary amino acids, whose relative abundance in the diet can account for the life-span effects of DR (17) . We tested three concentrations of amino acids (50, 100, and 200 N) and found that DMC extended life span of both male and female flies on each food type ( Table  S1 ). Thus, DMC appears to act via a different mechanism to the life-span extension by altered diet balance, adding extra life to flies whose life span has already been maximized by DR.
An attractive feature of drug interventions is the ability to modify their administration at any time in life. We tested the effect of early-life drug treatment by maintaining newly emerged adult flies on DMC-containing food for the first 20 days of adult life and then transferring them to a medium without DMC for the remainder of their lives. To test the effects of late-life administration, another group was fed medium without DMC for the first 42 days of adult life, after which they were transferred to, and maintained on, medium containing DMC. We found that irrespective of whether DMC treatment was restricted to early or later life, life span was significantly extended compared to controls, and there were no significant differences between the three DMC-treated groups ( Figure 1E ; Supplementary Table S1 ). Thus, DMC can elicit indistinguishably beneficial effects on total life span whether treatment is lifelong, or restricted to early or later life.
The Effect of DMC on Fecundity, Physical Activity, and Intestinal Integrity Ideally antiaging drugs should be able to prolong life span without reducing fertility. We found that DMC had a positive effect on female egg laying at intermediate (100 N) (p < .001, t-test) and high levels of dietary amino acids (200 N) (p < .05, t-test) but had no effect at low levels amino acids (50 N) (p > .05, t-test) (Figure 2A ), indicating no negative side-effects of the drug.
To assess the health of long-lived flies under treatment, we examined whether DMC altered the flies' inherent tendency to climb up a vertical surface (22) . We found that DMC did not affect the climbing ability of females at any age (p > .05; Supplementary Figure S3 ) and significantly improved it in mid to late life for males (p < .05; Figure 2B ).
Intestinal integrity is an important marker of aged physiological health in various species (23) (24) (25) (26) . We investigated the effect of DMC on intestinal health by feeding the flies on standard medium containing 2.5% indigo, a dye that in healthy flies is not absorbed from the gut. The number of flies in which the dye was observed to traverse the gut barrier ("smurfs" (26)) after 9 hours on dyed food was counted. We found that DMC significantly decreased the proportion of smurfs in both 30-day-old and 40-day-old females compared with controls (p < .05; Figure 2C ), indicating that DMC improved gut barrier function. Intestinal flora also increases sharply with aging, and the number of intestinal bacteria in older individuals is significantly higher than younger individuals (19) . We found that DMC significantly reduced the number of colony forming units of all analyzed bacterial phylotypes from the guts of 40-day-old flies (p < .01; Figure 2D ) similar to our previous finding for rapamycin (18) . Taken together, DMC elicited improvements in markers of intestinal health as the flies aged.
The Effect of DMC on Stress Tolerance
Improved stress tolerance is strongly associated with enhanced life span in various model organisms, a relationship that has traditionally thought to be causal (27) . We therefore examined if it was also the case for DMC-induced longevity. Flies were fed on medium with DMC for the first 10 days of adult life and then tested for tolerance to heat, starvation, desiccation, paraquat, and H 2 O 2 . DMC significantly increased the tolerance to heat stress in females (survival time increased up to 18.5%; Figure 2E ; Supplementary Table S1) and males (survival time increased up to 8.8%; Figure 2F ; Supplementary  Table S1 ). Similar to other long-lived flies (28), DMC-treated females and males were more starvation resistant than controls (survival time increased up to 15.1% in females- Figure 2G ; survival time increased up to 7.3% in males- Figure 2H ; Supplementary Table  S1 ) possessing higher energy stores in the form of triacylglycerol (p < .01; Figure 2I ). DMC treatment had no protective effect for either gender against desiccation, treatment with the superoxide Table S1 ); however, it also had no negative effects indicating longer life was not gained through a cost to basic stress resistance.
Intact Insulin Signaling Is Required for DMC to Modify Life Span
In order to examine the potential for DMC to interact with IIS for its longevity effects, we measured phosphorylation of the signaling intermediate Akt. At the same concentration as that which maximized life span, DMC administration caused a reduction in phosphorylation of T308-Akt to approximately half the level as found in controls ( Figure 3A) . To test if this apparent reduction in IIS could mediate DMC longevity, we tested the drug's effects on flies in which PDK1 or Akt was downregulated by inducible RNAi. In PDK1 and Akt knockdown flies, we found a significant increase in starvation resistance and life span (Figure 3B-E; Supplementary Table S1 ), similar to what is known for other long-lived IIS mutant flies (28, 29) .
Treatment with DMC failed to improve starvation tolerance and life span further in PDK1 and Akt knockdown flies (Figure 3B-E;  Supplementary Table S1 ). We investigated whether this failure of DMC to modify starvation resistance or life span was due to some unexpected interaction between DMC and RU486, but this was not the case as DMC administration could still enhance starvation tolerance and extended life span of the driver control with RU486 present (Figure 3F and G; Supplementary Table S1 ).
The Role of TOR Signaling in the Life-Extending Effect of DMC
The TOR pathway is another well-validated signaling pathway for its impacts on cell metabolism and aging. Reduction-of-function mutations in the TOR pathway have been shown to increase life span in diverse organisms (30) . Akt activates TORC1 by phosphorylating TSC2 and PRAS40, which establishes a link between IIS and TOR signaling. DMC may thus also inhibit TOR, either indirectly via reducing Akt phosphorylation, or directly by some other means. Indeed, we found a decrease in phosphorylation of the translational repressor 4E-BP, which lies downstream of TOR, in DMC-treated flies ( Figure 4A ). In order to further assess the role of TOR in the physiological changes caused by DMC treatment, we downregulated S6K and 4E-BP by RNAi and found that, knockdown of S6K significantly increased Drosophila starvation resistance, and this was unaffected by DMC treatment ( Figure 4B ; Supplementary Table  S1 ). In addition, knockdown of S6K also increased Drosophila life span in nonstarvation conditions and DMC failed to extend it further. (Figure 4C ; Supplementary Table S1 ). RNAi of 4E-BP in adult flies had no obvious effect on starvation resistance, but it was sufficient to block the starvation resistance caused by DMC treatment ( Figure 4D ; Supplementary Table S1 ). Similarly, DMC did not alter 
-test). (B) Driving
RNAi against PDK1 by daGS-GAL4 improved the starvation resistance of female flies (survival time extended up to 14%, p = .0007, log-rank test, compared to control) and DMC failed to improve this resistance further (p = .68, log-rank test, compared to green line). (C) Downregulation of PDK1 increased Drosophila life span up to 5.6%, from 62 to 65.5 days (p < .0001, log-rank test, compared to control). Knockdown of PDK1 abolished DMC-mediated changes to life span (p = .44, log-rank test, compared to green line). (D) Driving RNAi against Akt improved the starvation resistance of female flies up to 11.4% (p < .0001, log-rank test, compared to control) and DMC failed to improve this resistance (p = .099, log-rank test, compared to green line). (E) Downregulation of Akt increased Drosophila life span up to 12.4%, from 59.7 to 67.1 days (p < .0001, log-rank test, compared to control). Knockdown of Akt abolished DMC-mediated changes to life span (p = .56, log-rank test, compared to green line). (F) RU486 (20 µM) had no effect on the starvation resistance of daGS-GAL4 > w1118 flies (p = .92, logrank test, compared to control) but 0.5 µM DMC significantly enhanced it (survival time extended up to 8.1%, p = .0066, log-rank test, compared to control). (G) RU486 (20 µM) did not change the life span of daGS-GAL4 > w1118 flies (p = .83, log-rank test, compared to control), but DMC significantly increased its life span up to 8%, from 60.3 to 65.1 days (p < .0001, log-rank test, compared to control). 23 .2%, p < .0001, log-rank test, compared to control). DMC failed to improve the starvation resistance in S6K-RNAi flies (p = .73, log-rank test, compared to green line). (C) Downregulation of S6K increased Drosophila life span up to 6.7%, from 49 to 52.3 days (p < .0001, log-rank test, compared to control). Knockdown of S6K abolished DMCmediated changes to life span (p = .38, log-rank test, compared to green line). (D) Downregulation of 4E-BP had no effect on the starvation resistance of fruit flies (p = .45, log-rank test, compared to control) and DMC had no effect on starvation resistance in 4E-BP-defective flies (p = .092, log-rank test, compared to control). (E) Downregulation of 4E-BP increased Drosophila life span up to 14.3%, from 53.3 to 60.9 days (p < .0001, log-rank test, compared to control). Knockdown of 4E-BP abolished DMC-mediated changes in life span (p = .076, log-rank test, compared to green line).
the life span of 4E-BP knockdown flies which were long lived compared to controls ( Figure 4E ; Supplementary Table S1 ). These results indicate that normal levels of TOR pathway outputs are required for the effects of DMC on starvation tolerance and longevity in Drosophila.
Inhibition of TOR has important influence on multiple downstream metabolic pathways, including the activation of autophagy (31) . After pretreating flies with DMC, we detected an increase of autophagosomes in their midgut epithelial cells (Figure 5A and  B) . In addition, the transcription levels of autophagy-related genes atg1, atg5, and atg8a were upregulated significantly in DMC-treated flies ( Figure 5C ). In order to further explore the role of autophagy in the life-extension effect of DMC, we drove expression of RNAi against atg1 and atg5. For both lines, we found no significant effect on starvation tolerance, but adding DMC significantly improved it (Figure 5D and E; Supplementary Table S1 ). Knockdown of atg1 and atg5 significantly decreased Drosophila life span, but interestingly, and unlike TOR pathway interventions, DMC increased the life span of both atg1-RNAi and atg5-RNAi lines (Figure 5F and G; Supplementary Table S1 ). These data show that while DMC treatment of control flies appears to increase autophagy in the gut, its life-span-extending properties are not blocked by atg knockdown.
Co-administration of DMC and Rapamycin Do Not Produce Additive Effects on Life Span
Since DMC appears to require some downstream aspects of TOR signaling to effect life-span extension, but not others, we explored if a more comprehensive TOR knockdown, using the longevity drug rapamycin, in combination with DMC could produce additive effects on life span. Using concentrations of DMC and rapamycin that maximized life span when independently administered (Supplementary Figure S6 and Table S1 ), we saw no evidence for an additive effect of the two drugs on life span in either sex and in females, the combined effect appeared to be less than the two administered separately (Figure 6A and B; Supplementary Table S1 ). The two drugs combined also caused a decreased fecundity similar to the effect of rapamycin alone ( Figure 6C ). This pattern of lifespan response is similar to that seen for higher-than-optimal doses for each drug administered separately and may therefore represent the detrimental effects of over-suppressing TOR and/or IIS signaling. 
-test).
(D) Downregulation of atg1 had no effect on the starvation resistance of fruit flies (p = .15, log-rank test, compared to control). DMC significantly improved the starvation resistance in atg1 knockdown flies (survival time extended up to 13.2%, p = .0012, log-rank test, compared to control). (E) Downregulation of atg5 had no effect on the starvation resistance of fruit flies (p = .69, log-rank test, compared to control). DMC significantly improved the starvation resistance in atg5 knockdown flies (survival time extended up to 7.9%, p = .008, log-rank test, compared to control). (F) Downregulation of atg1 decreased Drosophila life span by 35%, from 57.4 to 37.3 days (p < .0001, log-rank test, compared to control). DMC significantly increased the life span in atg1 knockdown flies up to 10.2%, from 37.3 to 41.1 days (p < .0001, logrank test, compared to green line). (G) Downregulation of atg5 decreased Drosophila life span by 21.1%, from 62.2 to 49.1 days (p < .0001, log-rank test, compared to control). DMC significantly increased the life span in atg5-knockdown flies up to 9.2%, from 49.1 to 53.6 days (p = .0001, log-rank test, compared to green line). 015, log-rank test, compared to control), and rapamycin extended life span in male flies up to 7.2%, from 40.3 to 43.2 days (p = .049, log-rank test, compared to control), but their combined effect was not additive and failed to increase life span (p = .41, log-rank test, compared to control). (B) DMC extended life span in female flies up to 9.7%, from 68.1 to 74.7 days (p < .0001, log-rank test, compared to control), and rapamycin extended life span in female flies up to 6%, from 68.1 to 72.2 days (p = .019, log-rank test, compared to control), but their combined effect was not additive (p = .62, log-rank test, compared to control). (C) DMC slightly increased the fecundity of control fruit flies, adding rapamycin alone or co-administration of DMC and rapamycin significantly decreased fecundity to a similar extent (*p < .05, t-test). (D) Schematic representation of DMC-and rapamycin-mediated longevity. n.s. = nonsignificant.
Discussion
The steroid drug celecoxib increases the life span of Caenorhabditis elegans by inhibiting the phosphorylation of PDK1 in the IIS pathway (11) . Unfortunately, the potential advantages of celecoxib as an antiaging drug is limited by its COX-2 inhibitory activity which is associated with kidney injury, gastrointestinal dysfunction, and increased risk of cardiovascular disease (7) . DMC is a derivative of celecoxib and possesses most of its pharmacological properties except for the COX-2 inhibitory activity (12) . Thus, DMC could be an alternative to celecoxib as a drug to slow aging. In the present study, we explored the antiaging effect of DMC on Drosophila and found it to have positive effects on the life span of both sexes. Interestingly, DMC treatment also slightly improved the fertility of females, improved intestinal integrity and some kinds of stress resistance such as the tolerance to starvation and heat of both sexes, and improved vertical climbing ability in males. Importantly, in no assay did we find any detrimental side-effects. Thus, DMC can increase both life span and health span in flies.
A particularly interesting feature of DMC on life span is the ability for relatively small treatment windows to elicit long-term benefits. If DMC acted simply by reducing an acute and reversible risk of death at any given age, we would anticipate that early-life treatment with DMC would produce a reduced benefit later in life similar to the effect of DR (32) . Instead, the long-lasting benefit of early-life treatment indicates that DMC acts to slow the underlying process of aging, such that for every day on DMC, the flies gain additional days of life. Importantly, the full life-span benefit is still apparent when treatment is started at middle age, indicating useful therapeutic properties. It will be interesting in future studies to test the limits of late-life administration to enhance life span, as we would expect treatments that slow aging to yield diminishing benefits as initiation is started later in life.
The IIS and TOR pathways are the two most heavily studied pathways associated with aging and reduction of function in components of either pathway can prolong life in worms, fruit flies, and mammals (4) . Here, we found that the life-span-modifying effects of chronic treatment with DMC required normal expression of genes involved in both insulin and TOR signaling and that coadministration of DMC and rapamycin did not produce additive effects on life-span extension ( Figure 6D ). If the life-span-extending action of DMC acts through these pathways, this may indicate that there is no additive effect on life-span extension of inhibiting both IIS and TOR pathways at the same time. This is compatible with data from the long-lived chico mutant of Drosophila, in which the life-extending effects of rapamycin were completely abolished (1). Furthermore, in worms, knockdown of TOR in daf-2 mutants failed to augment their already extended life span (33) . Interestingly, although DMC upregulated the transcription of autophagy-related genes and significantly increased autophagosomes in Drosophila, its administration could still extend life in flies with atg1 or atg5 knocked down. This is unlike rapamycin, which failed to extend life span in atg5 knockdown flies (1) . Together, these data indicate that DMC's action via TOR signaling to extend life is via a nonidentical route to that of rapamycin. Thus, while the ability of DMC to inhibit both IIS and TOR may be critical for its antiaging effects, it is not clear what is the molecular route downstream of these elements that is critical for longevity. We also note that DMC treatment resulted in longer life for both males and females and did not reduce female fertility, thus its beneficial actions may involve additional routes than simple downregulation of IIS and/ or TOR signaling. It will be important in future studies to focus on understanding these complex interactions, as well as to validate these outcomes in mammalian model organisms, with metabolic biochemistry more similar to humans.
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